Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
about
Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selectionEarly immune adaptation in HIV-1 revealed by population-level approaches.Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant.Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patientUneven genetic robustness of HIV-1 integrase.Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.Comparison of experimental fine-mapping to in silico prediction results of HIV-1 epitopes reveals ongoing need for mapping experiments.Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.Impaired Nef function is associated with early control of HIV-1 viremia.Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C InfectionSelective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir
P2860
Q28088514-A214F317-DEA9-4825-B85F-10079290A01DQ34308788-DB69B092-8708-47D0-9E01-01BF49D79330Q34745316-2B132143-AFF3-436B-83A2-90EB4E06832EQ34871994-661116B6-7E09-471A-91DE-B79FCA7F1DCDQ35360391-7DFE3963-BD2E-4C7F-8C88-4FA0D9F2B554Q36281754-81627B77-FBA4-4D0D-9FE1-5A0660ECFC3CQ36301732-5AE9D29A-6055-415E-8CD2-FDCBCA418FD4Q36414604-A7D5BE2B-FFF6-4EF6-B6F7-93D52A5C9549Q38184579-4532327C-4D14-4B35-819C-F3CBE49ED7A4Q39005162-A4E68F03-9FEB-4889-8B40-8F5171D89DB5Q40428899-309D441C-20E4-4998-8F89-266086B0720BQ40501405-1FA7FD76-45AE-491B-A1C2-F66616BACED4Q42208915-7B50032E-0295-4BE4-9667-617E42F751C5Q57206384-50422307-72BC-4E15-9C14-5AD304F0135EQ58770498-04697FE3-7B54-4269-92B2-791F258B0E2B
P2860
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
@ast
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
@en
type
label
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
@ast
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
@en
prefLabel
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
@ast
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
@en
P2093
P2860
P50
P356
P1433
P1476
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
@en
P2093
Anthony D Kelleher
Denis R Chopera
Eric Martin
Heiko Jessen
Jennifer Sela
Jonathan M Carlson
Jorge Sanchez
Martin Markowitz
P2860
P304
P356
10.1128/JVI.07133-11
P407
P50
P577
2012-04-11T00:00:00Z